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The variant simian immunodeficiency virus termed SIVsmmPBj14 induces a rapidly fatal disease in pig-tailed macaques.
The acute pathogenic effects of this virus appear to be associated with at least two in vitro characteristics: the ability to
induce lymphocyte proliferation; and the ability to replicate in unstimulated PBMC. Two of the amino acids in Nef of PBj14
(the No. 17 residue, tyrosine, and the No. 18 residue, glutamic acid) appear to be linked to the virus’ ability to induce
lymphocyte activation. To further study the effects of these amino acids on PBj14-induced pathogenesis, we generated two
mutant viruses from our molecular clone, PBj6.6, containing either changes in both the No. 17 and No. 18 residues (termed
PBj6.6YE-RQ), or a single change in the No. 17 residue (termed PBj6.6Y-R). In vitro analyses of these viruses showed that
while their replicative abilities in stimulated peripheral blood mononuclear cells (PBMC) were altered, they still maintained
the ability to replicate in unstimulated PBMC. Replication of these viruses in macrophage populations was impaired relative
to the wild-type virus. Both mutant viruses were unable to induce proliferation of macaque PBMC in vitro. Virus derived from
PBj6.6Y-R was unable to induce acute disease in macaques, but did maintain the ability to induce lymphopenia and intestinal
lymphoid hyperplasia. These results show that the tyrosine-17 residue of Nef is linked to lymphocyte proliferation and
disease development, but also suggest that the pathogenic characteristics of SIVsmmPBj14 are dependent upon multiple
genetic determinants. © 1998 Academic Press
INTRODUCTION
The primate lentiviruses, human immunodeficiency vi-
rus types 1 and 2 (HIV-1, HIV-2), and simian immunode-
ficiency virus (SIV) from macaques (SIVmac) and sooty
mangabey (SIVsmm) are associated with the develop-
ment of AIDS in their respective hosts: HIV-infected hu-
mans; SIV-infected macaque monkeys (Barre-Sinoussi et
al., 1983; Gallo et al., 1984; Clavel et al., 1986; Letvin et al.,
1985; Murphey-Corb et al., 1986). In addition, HIV-1 has
been recently shown to induce AIDS in a chimpanzee
(Novembre et al., 1997). These viruses are very similar in
their structure, and in the organization and content of
their genomes, with SIVmac and SIVsmm being more
closely related to HIV-2 than HIV-1 (Chakrabarti et al.,
1987; Hirsch et al., 1989). The disease pattern induced by
SIVmac and SIVsmm, in susceptible animals, is remark-
ably similar to HIV-induced AIDS and consists of chronic
CD41 cell depletion leading to immunosuppression, the
development of opportunistic infections and neoplasia,
and eventually death (Letvin et al., 1985; Murphey-Corb
et al., 1986; McClure et al., 1989). The SIV-infected ma-
caque is probably the best model system for investiga-
tions into the pathogenesis of HIV-induced disease.
The primate lentiviruses are distinguished from other
retroviruses by the presence of a number of accessory
genes that enhance or facilitate viral replication. One of
these genes, nef, encodes a myristolated protein that is
expressed early after virus infection (reviewed in Cullen,
1994; Ratner and Niederman, 1995), and is also present
in the mature virion (Bukovsky et al., 1997). Originally
identified as a negative factor (Terwilliger et al., 1986;
Luciw et al., 1987), Nef has now been shown to play a
significant role in the pathogenesis of AIDS. As deter-
mined in vitro, the Nef protein appears to have multiple
functions. Nef has been shown to (i) influence viral rep-
lication by promoting an increased rate of viral DNA
synthesis (Schwartz et al., 1995; Chowers et al., 1995); (ii)
down-regulate cell-surface CD4 and MHC molecules
(Garcia and Miller, 1991; Benson et al., 1993; Foster et al.,
1994; Schwartz et al., 1996); and (iii) affect cell-signaling
pathways, possibly by association with a cellular serine
kinase (Baur et al., 1994; Greenway et al., 1995). While
these studies suggest that Nef may play an important
role in pathogenesis, the most compelling evidence
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comes from studies with SIVmac239 containing a de-
leted nef gene (SIVmac239Dnef). Adult macaques in-
fected with SIVmac239Dnef did not develop AIDS (Kes-
tler et al., 1991), and were subsequently protected from
infection with the pathogenic SIVmac251 (Daniel et al.,
1992). However, more recent studies have shown that the
SIVmac239Dnef virus can be pathogenic for neonatal
macaques (Baba et al., 1995; Wyand et al., 1996).
We have extended the studies on nef-deleted viruses,
focusing on the SIVsmmPBj variant. This virus induces
an acutely lethal disease in pig-tailed macaques char-
acterized by fulminant diarrhea, acidosis, anorexia, and
dehydration (Fultz et al., 1989). Molecular clones of this
virus reproduce disease (Dewhurst et al., 1990; Novem-
bre et al., 1993) and have been used for studying viral
determinants involved in acute pathogenesis (Novembre
et al., 1993, 1994). A nef-deleted form of SIVsmmPBj
(PBj6.6Dnef) has been constructed and is unable to in-
duce acute disease in macaques, suggesting that Nef
has an important function early on in the pathogenesis of
SIV (Novembre et al., 1996). Additionally, animals inocu-
lated with the PBj6.6Dnef have not developed AIDS for
up to 3.5 years. The Nef protein of SIVsmmPBj14 con-
tains a unique amino acid configuration at the amino
terminus. Beginning with the tyrosine at position 17 and
continuing through the lysine at position 31, this se-
quence of amino acids forms an immunoreceptor ty-
rosine-based activation motif. The importance of this
motif in SIV pathogenesis has just recently been noted. A
mutant of SIVmac239 was generated by changing nef
amino acids 17 and 18 to be like that of PBj14. The
resulting virus was shown to behave remarkably simi-
larly to the SIVsmmPBj14 variant, inducing an acute dis-
ease following in vivo inoculation into macaques (Du et
al., 1995). In vitro, this virus was able to replicate in
unstimulated cells, a feature that was only previously
observed with the PBj14 variant. Additional experiments
with a molecular clone of SIVsmmPBj14 (PBj1.9), con-
ducted by mutating the tyrosine-17 and glutamate-18
residues of Nef, suggest that these amino acids are
important determinants in the acute pathogenesis of
SIVsmmPBj (Du et al., 1996).
The results presented in this study confirm and extend
the previous results of Du et al. We have generated nef
mutants of the uniformly lethal PBj6.6 molecular clone.
Clones containing the mutations at the Y-17 (tyrosine to
arginine; Y-R) or YE-17,18 (tyrosine and glutamic acid to
arginine and glutamine; YE-RQ) residues are unable to
induce peripheral blood mononuclear cell (PBMC) prolif-
eration in vitro, but maintain the ability to grow in un-
stimulated PBMC. In vivo, the virus containing a Y-R
mutation at amino acid residue 17 of Nef of PBj6.6 is not
acutely pathogenic. Additional in vitro and in vivo analy-
ses of these viruses suggest that the acutely pathogenic
nature of SIVsmmPBj is primarily related to the ability of
the virus to induce PBMC proliferation.
RESULTS
Replication of viruses containing mutant nef alleles.
Transfection of the PBj6.6Y-R and PBj6.6YE-RQ plasmids
into CEM 3 174 cells produced infectious viruses as
determined by reverse transcriptase (RT) activity. These
viruses were also able to induce significant CPE in these
cultures by 3 days posttransfection. At peak RT activity,
supernatants were harvested, aliquoted, and stored un-
der liquid nitrogen. To determine the characteristics of
mutated viruses, a number of experiments were per-
formed. PBj6.6Y-R and PBj6.6YE-RQ were first compared
to the wild-type PBj6.6 virus for their replication abilities
in stimulated pig-tailed macaque PBMC. Results of these
studies are shown in Fig. 1A. Viruses derived from PBj6.6
molecular clone replicated in typical fashion, with a large
amount of RT activity being detected by day 6 postinfec-
tion. Maximum levels of RT activity for PBj6.6 were de-
tected at day 9 postinfection. The replication kinetics of
PBj6.6Y-R and PBj6.6YE-RQ were delayed when com-
pared to PBj6.6 and this was most evident with the
PBj6.6YE-RQ virus. The peak of replicative activity for the
mutated viruses was detected between days 12 and 15
postinfection.
One of the unique characteristics of SIVsmmPBj is the
ability to replicate to high titers in unstimulated cells. To
determine if the mutations generated had an effect on
this characteristic, the PBj6.6Y-R and PBj6.6YE-RQ vi-
ruses were tested for their ability to replicate in resting
cells. Both viruses were able to grow in unstimulated
cells. As shown in Fig. 1B, similar results to those de-
scribed with stimulated cells were obtained in these
experiments. Again, the wild-type virus, PBj6.6, repli-
cated with faster kinetics than the nef-mutated viruses,
with the peak of reverse transcriptase activity being at 9
days postinfection. As with the stimulated cells, the
PBj6.6/YE-RQ virus displayed the slowest kinetics in un-
stimulated cells, reaching a peak by day 15 postinfection.
In both cases (stimulated and unstimulated cells), the
mutated viruses grew to higher titers than the wild type
PBj6.6.
In the report by Du et al. (1995), it was shown that
although the SIVmac239 virus containing the YE mutation
could replicate in unstimulated cells, the presence of
macrophages was required. We sought to evaluate the
replication of our PBj6.6 nef mutants in a similar manner.
To test if either the wild-type or mutant viruses could
replicate in macrophage-depleted cell populations, pig-
tailed macaque PBMC were depleted of macrophages
by combined adherence and antibody-based negative
selection and used in replication experiments. These
results are presented in Fig. 2. All viruses were able to
replicate well in these cultures. Similar to the experi-
ments described above, the kinetics of replication of
PBj6.6 was somewhat faster than the kinetics of the
nef-mutant viruses and peaked at an earlier time point
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(days 6–8 versus days 8–12 for the mutated viruses).
Again, the PBj6.6Y-R and PBj6.6YE-RQ viruses were able
to replicate to higher titers than the wild-type virus.
Virus-induced cellular proliferation. Another distin-
guishing characteristic of SIVsmmPBj is the ability of the
virus to induce proliferation of PBMC as measured in
vitro (Fultz, 1991). This characteristic is directly associ-
ated with the viruses’ ability to induce acutely lethal
disease (Novembre et al., 1993). Recently, the nef allele
has been associated with this ability (Du et al., 1995,
1996). We therefore chose to examine our mutant clones
for the ability to induce proliferation. As shown in Fig. 3A,
the wild-type PBj6.6 virus induced typical proliferation in
pig-tailed macaque PBMC, with a stimulation index of
36.9. However, both the PBj6.6Y-R and PBj6.6YE-RQ vi-
ruses were unable to induce proliferation (stimulation
indices of 1.5 and 1.4, respectively). Based upon our
previous studies, these in vitro results suggested that the
mutated viruses would not induce acutely lethal disease
in vivo. Because the replication of both mutant viruses
was delayed with respect to the PBj6.6 virus, it was
thought that induction of proliferation might also be de-
layed. The results presented above were derived from
pulsing cultures at day 6. Figure 3B shows the results of
similar experiments that were taken out to day 10 before
pulsing (approximate peak replication of mutant viruses).
Again, the PBj6.6 virus induced significant proliferation in
the PBMC culture; however, this proliferative effect is
reduced from that observed at day 6. The mutant viruses,
PBj6.6Y-R and PBj6.6YE-RQ, were again unable to induce
proliferation.
Replication in macrophages. Because SIVsmmPBj14 is
highly macrophage tropic in vivo, we sought to examine
the effect of these mutations on the ability of the virus to
replicate in macrophages in vitro. Monocyte-derived
macrophages were inoculated with equal concentrations
(p27) of virus derived from either the PBj6.6 clone, the
PBj6.6Y-R clone, or the PBj6.6YE-RQ clone. At 7 days
postinfection, there are already differences detectable
between the PBj6.6 virus and the other nef mutant vi-
FIG. 1. Replication of PBj6.6 nef mutants in pig-tailed macaque PBMC. Viruses derived from molecular clones PBj6.6, PBj6.6Y-R, and PBj6.6YE-RQ
were used to infect Con A-stimulated (A) or unstimulated (B) macaque PBMC. Cell-free supernatants were harvested from the cultures at the indicated
time points and tested for the presence of reverse-transcriptase activity.
FIG. 2. Replication of PBj6.6 nef mutants in macrophage-depleted
PBMC. Viruses derived from molecular clones PBj6.6, PBj6.6Y-R, and
PBj6.6YE-RQ were used to infect unstimulated macaque PBMC that
had been depleted of macrophages by adherence and negative selec-
tion. Cell-free supernatants were harvested from the cultures at the
indicated time points and tested for the presence of reverse-tran-
scriptase activity.
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ruses, represented by lower accumulated p27 antigen
levels (Table 1). By 14 days postinfection, the differences
are highly pronounced and statistically significant with
the PBj6.6 virus replicating to high titers and both the
PBj6.6Y-R and PBj6.6YE-RQ viruses replicating to low
titers in the macrophages.
Infection of pig-tailed macaques with PBj6.6Y-R. Both
nef mutants exhibited similar characteristics in replica-
tion and proliferation experiments. As mentioned above,
because these viruses did not induce PBMC proliferation
in vitro, it was suspected that they would not induce
acutely lethal disease in vivo. To investigate what effects
the change of the tyrosine residue had on the in vivo
effects of the virus, PBj6.6Y-R was inoculated iv into three
juvenile pig-tailed macaques. One animal was sacrificed
on day 6 postinoculation and one animal was sacrificed
on day 10 postinoculation. The third animal was followed
until it died. This design permitted an examination of the
early events in the pathogenesis of the nef-mutant virus,
and allowed direct comparison with animals dying of
PBj-induced disease.
One of the characteristic features of SIVsmmPBj14
infection in pig-tailed macaques is the development of
acute lymphopenia in CD41, CD81, and CD201 cell
types (Israel et al., 1993; Novembre, unpublished obser-
vations). Examination of CD41 levels in the PBj6.6Y-R-
infected animals shows similar trends in lymphopenia
when compared with PBj6.6-infected animals (Fig. 4).
CD41 cell decline is observed by day 3 in these animals,
and is most prominent by day 6 postinfection. This lym-
phopenia was also extended to other cell populations (B
cells, CD81 T cells; data not shown). While lymphopenia
developed by day 6 in all animals, there was no sign of
clinical disease—diarrhea, anorexia, dehydration, or
loss of activity. The macaque that was kept alive after the
initial infection phase showed a steady decrease in the
CD41 cell levels (Fig. 4B). This animal died 339 days
after infection with lymphadenopathy and thrombosis
due to SIV infection.
The virus was easily isolated from the PBMC of the
three pig-tailed macaques inoculated with the nef-mu-
tant virus, beginning by day 3 postinfection (data not
shown), suggesting that the virus was able to replicate
well in these animals. To investigate viral loads in these
macaques, plasma p27 antigen levels were determined.
When compared with historical PBj6.6 controls, it was
found that plasma p27 levels at day 6 postinfection (typ-
ically the point of highest plasma antigenemia in PBj6.6-
infected animals) were significantly lower in the animals
inoculated with the PBj6.6Y-R virus (Table 2). To be sure
that there was not a delayed replication effect, p27 levels
in the surviving animals were analyzed at subsequent
time points. At day 10 postinfection, one of the remaining
two animals had lower p27 plasma levels than on day 6
(PCf-1, 0.392 ng/ml). The other remaining animal had
somewhat increased p27 plasma levels (PPf-1, 1.000 ng/
FIG. 3. Stimulation of lymphocyte proliferation by PBj6.6 nef mutants. Unstimulated PBMC from a pig-tailed macaque were incubated in triplicate
for either 6 (A) or 10 days (B) with either the indicated viruses, concanavalin A, or media from uninfected CEM 3 174 cells. After an 18-h incubation
in the presence of [3H]thymidine, cells were harvested and the uptake of radioactivity was measured for the determination of stimulation indices.
TABLE 1
Replication of PBj-Derived Viruses in Macaque Macrophages
Virus
p27 Antigen in supernatant (mean 6 SE; ng/ml)a
Day 7 (range) Day 14 (range)
PBj6.6 22.7 6 7.2 (8.0–34.2) 91.8 6 17.5 (67.4–127.1)
PBj6.6Y-R 5.6 6 2.6 (1.2–10.0)* 8.0 6 30 (3.3–14.9)*
PBj6.6YE-RQ 7.8 6 3.7 (2.2–16.1)* 8.9 6 3.4 (2.9–14.0)*
a p27 antigen was measured in supernatants of infected macro-
phages on the days after infection indicated.
* Statistically significant difference from results with PBj6.6-infected
macrophages.
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ml); however, this was still markedly less than plasma
levels observed in PBj6.6-infected animals at peak anti-
genemia. This animal, PPf-1, which was kept alive to
follow the development of AIDS, only demonstrated an-
tigenemia at one additional time point (21 days postin-
fection, 0.155 ng/ml). These results confirmed the results
generated in vitro and suggest that these mutant viruses
have lower replicative abilities when compared with the
wild-type PBj6.6 virus.
We have previously shown that SIVsmmPBj infection
and acute disease in pig-tailed macaques is correlated
with increased levels of apoptosis and cellular activation
in intestinal lymphoid tissue when compared with tis-
sues derived from uninfected or SIVmac239-infected ma-
caques (Gummuluru et al., 1996a,b). Because macaques
infected with PBj6.6Y-R did not develop acute disease,
we hypothesized that this was due to the lack of induced
immune activation, as suggested by the results of the in
vitro studies. To examine the in vivo effects of this virus,
pig-tailed macaques infected with PBj6.6Y-R were sacri-
ficed on day 6 (typical PBj6.6 time course of disease) or
day 10 (low dose PBj6.6 time course) postinfection (one
animal per time point). Intestinal tissues obtained from
these were used for comparative analyses with tissues
obtained from uninfected animals and animals dying of
PBj6.6-induced acute disease. Microscopic examination
of Peyer’s patch areas revealed that macaques infected
with the PBj6.6Y-R virus had developed significant lym-
phoid hyperplasia (Fig. 5B) when compared to tissue
from uninfected macaques (Fig. 5A), similar to that seen
in PBj6.6-infected animals (Fig. 5C). This is better illus-
trated in Fig. 5D, which shows the results of quantitative
comparisons performed on the Peyer’s patch tissue sam-
ples. Macaques inoculated with the PBj6.6Y-R virus (or
PBj6.6 virus) had significantly more area of cellular infil-
tration than uninfected animals. These results suggested
that this virus could possibly have some residual im-
mune-activation capability that was not detected in vitro.
To study this possibility, tissues were examined for the
following markers, previously found to be significantly
elevated in PBj6.6-infected macaques (Gummuluru et al.,
1996a,b): (1) apoptosis; (2) SIV antigen; (3) CD45RO ex-
pression; and (4) CD25 expression. Levels of apoptosis
were significantly less in tissues obtained from PBj6.6Y-R
animals when compared with PBj6.6 animals (Figs. 6B
and 6A, respectively). Significant differences were also
observed when comparing levels of SIV antigen (Figs. 6C
and 6D), CD45RO expression (Figs. 6E and 6F), and
CD25 expression (Figs. 6G and 6H); where tissues from
FIG. 4. Effects of SIVsmmPBj infection on circulating CD41 cell levels. (A) early (through day 10 postinfection) effects of PBj6.6Y-R on CD41 cell
counts in all three inoculated macaques (PHf-1, PCf-1, PPf-1). For comparative purposes, the CD41 cell counts in two animals infected with PBj6.6
virus are shown (PAy, PSv). (B) Complete CD41 cell level profile of macaque PPf-1 through date of death.
TABLE 2
Viremia in Macaques Infected with PBj6.6 or PBj6.6Y-R
Animal Virus Plasma p27 levela Meanb
PPf-1 PBj6.6Y-R 0.616
PHf-1 PBj6.6Y-R 0.204 0.555 6 0.27*
PCf-1 PBj6.6Y-R 0.845
PSv PBj6.6 13.284
PAy PBj6.6 9.619
PCw PBj6.6 9.677
42130 PBj6.6 2.304 9.770 6 5.96
42136 PBj6.6 8.336
42132 PBj6.6 3.561
4226 PBj6.6 21.606
a Plasma p27 antigen levels measured using the Coulter SIV core
antigen kit at day 6 postinfection (PBj6.6Y-R-infected animals), or day 5,
6, or 7 postinfection (date of death, PBj6.6-infected animals).
b Mean 6 standard deviation determined for p27 plasma values for
all macaques inoculated with the same virus.
* Statistically significant difference from results obtained with PBj6.6-
infected animals as determined by comparison of the means using
Scheffe’s test.
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PBj6.6Y-R animals had significantly lower levels than
tissues from PBj6.6-infected animals. Again, quantitative
analyses of these staining experiments shows these
results in an interpretable fashion (Fig. 6I). Thus, while no
evidence of activation related to virus infection was ob-
served in the PBj6.6Y-R-infected macaques, significant
levels of lymphoid invasion in gut tissue was seen.
DISCUSSION
It is now clear that the accessory genes of HIV and SIV
contribute significantly to the mechanism(s) of AIDS
pathogenesis in vivo. However, the precise function(s)
ascribed to each gene are still far from being fully de-
fined. The nef gene products of HIV and SIV have re-
FIG. 6. Immunocytochemical localization of apoptosis, SIV infection, and activation markers in intestinal tissue from SIV-infected macaques. Peyer’s
patch tissue from a PBj6.6-infected animal (A, C, E, G) and a PBj6.6Y-R-infected animal (B, D, F, H) were used to investigate the incidence of apoptosis,
the expression of activation-associated, markers and the expression of SIV antigen. Apoptotic nuclei are visualized using the TUNEL method [dark
nuclear stain; (A,B)]. SIV antigen-positive cells [purple cytoplasmic stain (C,D)], CD45RO-positive cells (black cytoplasmic stain (E,F)], and CD25-
positive cells [black cytoplasmic stain (G,H)] were identified by immunohistochemistry using specific antisera (see Materials and Methods).
Magnification is 380 in all photos. A quantitation of the mean number of positive cells for each item pictured in A–H is represented in panel I. A total
of nine fields were examined to determine the mean number of positive cells for each evaluation. The standard error for each item was 1 or less.
The asterisks represent statistically significant differences (P , 0.05).
FIG. 5. Histopathology of Peyer’s patch tissue in macaques. Peyer’s patch tissue was obtained from an uninfected macaque (A), a PBj6.6Y-R-
infected macaque (B), and a PBj6.6-infected macaque (C), fixed in formalin and embedded in paraffin. Tissue sections were cut and stained with
hematoxylin and eosin. Photomicrographs were taken of representative areas of each tissue. (D) Quantitation of surface area of tissue in A, B, and
C. Nine separate sections of each tissue were quantitated. The graph shows the calculated mean area for each tissue sample. The standard error
for each sample was 2 or less, in all cases. The asterisks represent statistically significant differences from uninfected tissue. Magnification is 360
in all panels.
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ceived a great deal of attention recently because of the
apparent lack of disease development in humans and
nonhuman primates infected with viruses containing
nonfunctional Nef proteins (Kestler et al., 1991; Kirchoff et
al., 1995; Deacon et al., 1995). While a number of activi-
ties have been directly associated with the nef gene
product in cells in vitro, the actual function(s) of nef,
which are directly related to disease development, have
not been clearly identified. However, recently, Nef of SIV
has been shown to function in cellular activation path-
ways, apparently associating with and inducing a p21-
activated kinase (PAK) (Sawai et al., 1995). The activation
of PAK appears to be associated with pathogenicity and
the development of AIDS (Sawai et al., 1996). Addition-
ally, a single amino acid change in Nef (tyrosine No. 17
residue) has been shown to alter the pathogenicity of an
SIV isolate (SIVmac239) from a virus that induces AIDS to
a virus that induces an acute disease similar to that of
SIVsmmPBj14 (Du et al., 1995). These recent data sug-
gest that Nef plays an important role in the early patho-
genesis of SIV/HIV infection.
We have been interested in the role of Nef in the
pathogenesis of PBj-induced disease. We have previ-
ously described the lack of acute disease development
in pig-tailed macaques infected with PBj6.6Dnef, a virus
lacking a functional nef gene, indicating the important
role that this protein plays in acute pathogenesis (No-
vembre et al., 1996). Indeed, studies have shown that in
PBj14-infected animals which survive the acute phase,
the nef gene no longer codes for the tyrosine No. 17
residue, further implicating this allele in pathogenesis
(Schwiebert et al., 1997). To further characterize the role
of Nef in the pathogenesis of PBj14-induced disease, we
generated two additional PBj mutants, PBj6.6Y-R and
PBj6.6YE-RQ, which contain single and double amino
acid changes in Nef, respectively. These mutations are
the converse of those generated in the SIVmac239 clone,
the result of which induced a PBj-like disease as previ-
ously reported (Du et al., 1995). In vitro analysis of our
mutant viruses demonstrated delayed replicative abili-
ties when compared with the parental virus, PBj6.6. The
results were observed in unstimulated, as well as stim-
ulated cell populations, and demonstrated that a single
amino acid mutation could affect replication kinetics in
vitro. However, these viruses still maintained the ability
to replicate in unstimulated PBMC, a notable character-
istic of PBj14. In a previously published study using the
SIVmac239YE mutant, the ability to replicate in unstimu-
lated cells has been shown to be dependent upon the
presence of macrophages as accessory cells (Du et al.,
1995). Our experiments presented here demonstrated
that depletion of macrophages did not hinder the ability
of these viruses to grow in unstimulated cells. These
results further suggest that multiple alleles contribute to
the unique characteristics of SIVsmmPBj. Replication in
macrophages in vivo is another characteristic of
SIVsmmPBj14. Localization of SIV infection in the gut
area of SIVsmmPBj14-infected macaques has shown a
predominance of infected macrophages (Zack et al.,
1989). The Y-R and YE-RQ mutations generated in the
PBj6.6 virus severely limited the abilities of the mutant
viruses to replicate in macrophages when compared
with the parental virus. While the ability to replicate was
not totally eliminated, as recently described for vpx de-
letion mutants of SIVsmmPBj (Fletcher et al., 1996), the
point mutations significantly reduced the growth charac-
teristics in macrophages.
The fact that PBj6.6Y-R and PBj6.6YE-RQ could not
induce PBMC proliferation suggests that separate do-
mains are responsible for replication in unstimulated
cells and for PBMC activation. Results of the PBMC
proliferation assay appear to correlate well with the abil-
ity of a virus to induce acutely lethal disease in vivo. The
data obtained for these mutant viruses suggested that
they would not induce acutely lethal disease in pig-tailed
macaques. This was confirmed after inoculating three
macaques with virus derived from the PBJ6.6Y-R clone.
None of the animals developed acute disease; however,
all displayed CD41 cell lymphopenia.
Because of the incidence of CD41 cell lymphopenia
observed in PBj6.6Y-R-infected macaques, we chose to
investigate the possible development of intestinal pathol-
ogy, which may have occurred in the absence of clinical
disease. Analysis of the Peyer’s patch areas (focal point
for PBj-induced disease) in the animals sacrificed at 6
and 10 days postinfection showed significant levels of
lymphoid hyperplasia relative to uninfected animals. This
is a PBj14-specific characteristic and does not appear to
occur at early times with other pathogenic SIV isolates
(Veazey et al., 1997). Thus, it is reasonable to state that
the PBj6.6Y-R virus maintains some wild-type character-
istics in vivo. Examination of intestinal tissue for other
PBj-induced effects showed that levels of apoptosis and
immune activation, as well as SIV expression, were sig-
nificantly less than that seen with wild-type PBj14 infec-
tion and are similar to previously reported results with
typical SIV infection in macaques (Gummuluru et al.,
1996a,b). These data suggest that the PBj6.6Y-R mutant
can induce lymphocyte homing to the intestinal area
(similar to wild-type PBj14 [Gummuluru et al., 1996b]),
without inducing lymphocyte activation or proliferation.
Thus, the characteristic of SIVsmmPBj14 that is most
relevant to acute pathogenesis appears to be the induc-
tion of immune activation, which is represented in vitro
by stimulation of PBMC proliferation. However, it is also
possible that viral load contributes to the pathogenic
nature of the virus. This will need to be investigated
further. While the tyrosine-17 residue of Nef is undoubt-
edly linked to the ability of SIVsmmPBj14 to cause
acutely lethal disease, we do not believe that this is the
sole determinant involved. Evidence for this comes from
our previously characterized clones and chimeric clones
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which contain this nef allele, but do not induce prolifer-
ation in vitro or disease in vivo (Novembre et al., 1993,
1994). Thus, additional work is required to fully define the
determinants involved in the acute pathogenesis of
SIVsmmPBj14.
MATERIALS AND METHODS
Generation of mutant viruses. The molecular clone
PBj6.6 has previously been described (Novembre et al.,
1993). Plasmid DNA of a subclone of the 39 half of PBj6.6
(p396PBj/Nsi I-Nde I, 10 ng) was used as a template for
inverse PCR to generate mutations in the nef gene,
essentially as described previously (Novembre et al.,
1993). Reactions were performed in a total volume of 100
ml, containing: primers (20 pmoles each), dNTPs (200 mM
each), KCl (50 mM), Tris–HCl (pH 8.3, 10 mM), MgCl2 (2
mM), and Taq polymerase (2.5 units). The amplification
cycle was programmed as follows: 94°C for 4 min (initial
denaturation step) followed by 30 rounds of 94°C for 1
min, 60°C for 1.5 min, and 72°C for 5 min. Oligonucleo-
tides (synthesized on an Applied Biosystems 392 DNA
synthesizer) were as follows: (A) For generating the dou-
ble amino acid change (YE to RQ), forward primer 369,
59-GGAAATTTGCGCCAGAGACTCTTGCAAGCGCGTG-
GAG-39; reverse primer 370, 59-ACCACGCCTGCGCTG-
CTTCTTGGAGGTAACGCC-39; (B) for generating the sin-
gle amino acid change (Y to R); forward primer 371,
59-GGAAATTTGCGCGAGAGACTCTTGCAAGCGCGTG-
GAG-39; reverse primer 370 (listed above). Amplification
products were used for self-ligation to generate the
proper plasmids with changes. Changes were then con-
firmed by sequence analysis. The subclone containing
the correct changes was then inserted into the PBj6.6
molecular clone. Virus stocks were generated by trans-
fection of CEM 3 174 cells with the full-length clones
containing the desired mutations (PBj6.6Y-R and
PBj6.6YE-RQ). At peak RT activity, cell-free supernatants
from transfected cells were harvested, aliquoted, and
stored under liquid nitrogen. Virus stocks were quanti-
tated by measuring the amount of p27 antigen using a
commercially available assay (Coulter).
Replication and proliferation assays. Viral replication in
stimulated and unstimulated pig-tailed macaque PBMC
was performed as previously described (Novembre et al.,
1996). Infections were initiated by incubating 10 ng of input
virus with 1–2 3 107 cells. Following overnight incubation,
cells were washed and resuspended in the appropriate
media. Supernatants were sampled at various times postin-
fection for analysis of cell-free RT activity.
For depletion of macrophages, PBMC were cultured
overnight in RPMI 1640 media containing 15% human
AB1 serum to adhere out monocyte/macrophages. The
following day, cells were treated twice with beads coated
with anti-CD14 (a monocyte/macrophage marker; Dyna-
beads, Dynal, Inc.) to deplete remaining macrophages.
Cells were then used in replication experiments.
To measure virus-induced proliferation, unstimulated
PBMC were incubated with 1 or 10 ng of input virus. At 6
days postaddition of virus, [3H]thymidine was added to
the cultures. After 18 h, incorporated radioactive label
was determined and quantitated as described previously
(Novembre et al., 1993). Results are presented as stim-
ulation indices.
Macrophage replication. The ability of viruses to rep-
licate in pig-tailed macaque macrophages was evalu-
ated as follows. PBMC were isolated from blood ob-
tained from uninfected pig-tailed macaques by centrifu-
gation over lymphocyte separation media (LSM, Organon
Teknika). Cells (3 3 106/ml, in RPMI 1640 containing 15%
human AB1 serum, 1.5 ng/ml of M-CSF, and 0.08 ng/ml of
GM-CSF) were seeded into 24-well microtiter plates and
incubated for 4 days to allow adherence of monocytes.
Nonadherent cells were removed by gentle washing and
medium was replaced. Cells were incubated for another
3–4 days to allow full differentiation into macrophages.
Virus infections (in multiples of 10 wells/virus isolate)
were initiated by adsorption of 1 ng of input virus stock
overnight at 37°C. Following washes, cells were over-
layed with macrophage media. Fresh media was added
every 3–4 days. At 7 and 14 days postinfection, super-
natants were harvested and used to determine the levels
of p27 antigen present. Statistical analysis of macro-
phage replication studies was performed by comparing
the means among groups using a one-way analysis of
variance (SPSS Inc., 1994). Unplanned post hoc pairwise
comparisons of means were made via Scheffe’s test.
Animal inoculations and follow-up. Three juvenile pig-
tailed macaques (all negative for SIV, STLV, and SRV)
were inoculated iv with 104 TCID50 of virus derived from
the molecular clone PBj6.6Y-R. Animals were observed
daily for development of clinical disease. At 3 days
postinfection all animals were anesthetized, given a
physical exam, and were bled. One animal was sacri-
ficed on day 6 postinfection, and a second animal was
sacrificed on day 10 postinfection. Prior to necropsy,
animals were perfused with saline to purge blood from
tissues. At necropsy, blood and tissue samples were
obtained. Blood was used for the preparation of plasma
and PBMC was used for virus studies. Tissue samples
were separated into three parts and either (1) used as
fresh (for virus culture); (2) fixed in 10% buffered formalin
and paraffin embedded; or (3) quick frozen in OCT media.
The remaining animal was kept alive and observed for
clinical disease development (either PBj-like or AIDS-like
disease). Physical exams and blood collection (for virus
studies, CBC, and lymphocyte subset analyses) were
performed at monthly intervals. Juvenile macaques, pre-
viously infected with 104 TCID50 of virus derived from
molecular clone PBj6.6 and dying of acute disease, were
used for comparison.
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Virus detection and culture. Virus present in the
plasma of macaques was detected using an SIV p27-
specific ELISA (Coulter Diagnostics). Blood and tissue
samples were also used for virus isolation. For blood
cultures, macaque PBMC were separated by centrifuga-
tion of whole blood over LSM. Cells were then stimulated
with concanavalin A (Con A, 5 mg in RPMI 1640 contain-
ing 10% heat-inactivated fetal calf serum, 10% IL-2, 10
mM HEPES, and antibiotics) for 3 days before coculture
with CEM 3 174 cells. Maintenance of cultures and
detection of virus in culture supernatants were per-
formed as previously described (Novembre et al., 1992).
Flow cytometry. Lymphocyte subset analyses of inoc-
ulated macaques were performed on whole blood sam-
ples essentially as described previously (Ahmed-Ansari
et al., 1989).
Visualization of cellular morphology in tissues and
calculation of areas. Peyer’s patch tissue sections ob-
tained from SIV-infected and uninfected macaques were
deparaffinized and rehydrated. Sections were then
placed into hematoxylin (Gill’s Formula; Vector No.
H-3401) for 4 min, drained and rinsed in running water
until the effluent was clear. After rinsing, tissues were
destained and dipped into 70 and 95% ethanol for 2 min
each. Tissues were then placed in eosin Y (alcoholic,
Anatech No. 831) for 2 min, destained in 95% ethanol,
rehydrated, and mounted by coverslips. Digitized images
of stained sections were analyzed using a MCID densi-
tometer (Imaging Research Inc.). The densitomer was
calibrated by digitizing a distance standard (reticule), to
allow conversion of pixels into millimeters. Slides were
then examined, and .8 Peyer’s patches were selected,
to allow calculation of their area. Results were ex-
pressed as squared millimeters.
Detection of SIV antigen and immune activation. Par-
affin-embedded intestinal tissues were cut in 5-mm sec-
tions on a rotary microtome and mounted on slides coated
with Vectabond (Vector Corp). Tissues sections were
heated in a 56°C oven for 30 min, deparaffinized by immer-
sion in Propar (Anatech) for 15 min and then rehydrated in
a series of graded alcohols (100, 95, and 70% ethanol), prior
to immersion in phosphate-buffered saline (PBS), pH 7.4.
For antigen retrieval, tissue sections were processed by
heating in a microwave oven on high power for 10 min in 5%
urea in a covered plastic coplin jar. Jars were uncovered
and the solution was allowed to cool for 15 min. Sections
were then rinsed in PBS and tissue antigens were further
exposed by digestion of sections in 0.1% trypsin for 10 min
at room temperature. Tissue sections were then reacted
with 3% H2O2 in methanol in order to inactivate any endog-
enous peroxidase. Nonspecific binding was decreased by
incubating tissue sections with 10% normal horse serum or
10% normal goat serum (Vector Laboratories) for 1 h at
room temperature.
The following mouse monoclonal antibodies were used
in this study: (i) anti-CD45RO, clone UCHL1 (ready-to-use
quick-staining HRP reagent; Dako); (ii) anti-SIVmac/smm gp41,
clone KK41 (Kent et al., 1992) (1:200 dilution; NIH AIDS
Research and Reference Reagent Program); and (iii) anti-
CD25, clone M-A251 (Pharmingen, 1:500 dilution; reacts
with the a-chain of the IL-2 receptor and is specific for
activated T-cells). CD45RO represents a marker for both
resting memory T cells and for mature activated T lympho-
cytes, while the anti-SIV antibody is specific for cells that
are productively infected by SIV. Detection of bound anti-
bodies was performed using a horseradish peroxidase
conjugated avidin–biotin complex (Vector ABC, Vector Lab-
oratories). Chromagens used to visualize bound peroxi-
dase were nickel-enhanced diaminobenzidine or VIP (Vec-
tor Laboratories). Staining for CD25 was performed on
frozen tissue sections.
Detection of apoptotic nuclei. Tissue sections were
treated initially as described above except proteinase K
(20 mg/ml) was used as the digesting enzyme. After
quenching endogenous peroxidase, apoptotic nuclei
were detected by previously described methods (Gum-
muluru et al., 1996a), using a commercially available kit
(ApopTag peroxidase assay kit, ONCOR, Gaithersburg,
MD). Briefly, this assay detects free 39-OH ends of newly
cleaved DNA in situ, using the TUNEL (terminal de-
oxynucleotidyltransferase end labeling) methodology
(Gavrieli et al., 1992). Reactions were performed under
previously described conditions, and diaminobenzidine
was used to visualize positively stained nuclei. To verify
the specificity of TUNEL staining, negative control reac-
tions were conducted using Peyer’s patch specimens
from SIVsmmPBj14-infected animals, which were re-
acted with TUNEL reagents in the absence of the en-
zyme terminal deoxynucleotidyl transferase.
Image digitization. Digitized images of ApopTag- or
immunohistochemically stained sections in ,80 403
microscopic fields were analyzed for numbers of posi-
tively staining nuclei, using a densitometer (Imaging Re-
search Inc., Ontario, Canada), as described elsewhere
(Gelbard et al., 1995; Gummuluru et al., 1996a). Data
were expressed as the mean number of positive nuclei
per microscopic field 6 the standard error of the mean.
Tests of statistical significance between sample groups
were determined by paired t tests.
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